Literature DB >> 29566112

Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases.

Barney S Graham1, John R Mascola1, Anthony S Fauci2.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29566112     DOI: 10.1001/jama.2018.0345

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  32 in total

1.  Challenges and solutions in the development of vaccines against emerging and neglected infectious diseases.

Authors:  Joel N Maslow
Journal:  Hum Vaccin Immunother       Date:  2019       Impact factor: 3.452

2.  SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness.

Authors:  Kizzmekia S Corbett; Darin Edwards; Sarah R Leist; Olubukola M Abiona; Seyhan Boyoglu-Barnum; Rebecca A Gillespie; Sunny Himansu; Alexandra Schäfer; Cynthia T Ziwawo; Anthony T DiPiazza; Kenneth H Dinnon; Sayda M Elbashir; Christine A Shaw; Angela Woods; Ethan J Fritch; David R Martinez; Kevin W Bock; Mahnaz Minai; Bianca M Nagata; Geoffrey B Hutchinson; Kapil Bahl; Dario Garcia-Dominguez; LingZhi Ma; Isabella Renzi; Wing-Pui Kong; Stephen D Schmidt; Lingshu Wang; Yi Zhang; Laura J Stevens; Emily Phung; Lauren A Chang; Rebecca J Loomis; Nedim Emil Altaras; Elisabeth Narayanan; Mihir Metkar; Vlad Presnyak; Catherine Liu; Mark K Louder; Wei Shi; Kwanyee Leung; Eun Sung Yang; Ande West; Kendra L Gully; Nianshuang Wang; Daniel Wrapp; Nicole A Doria-Rose; Guillaume Stewart-Jones; Hamilton Bennett; Martha C Nason; Tracy J Ruckwardt; Jason S McLellan; Mark R Denison; James D Chappell; Ian N Moore; Kaitlyn M Morabito; John R Mascola; Ralph S Baric; Andrea Carfi; Barney S Graham
Journal:  bioRxiv       Date:  2020-06-11

3.  Development of a potent Zika virus vaccine using self-amplifying messenger RNA.

Authors:  Kate Luisi; Kaitlyn M Morabito; Katherine E Burgomaster; Mayuri Sharma; Wing-Pui Kong; Bryant M Foreman; Sonal Patel; Brian Fisher; Maya A Aleshnick; Jason Laliberte; Madison Wallace; Tracy J Ruckwardt; David N Gordon; Christine Linton; Nicole Ruggiero; Jessica L Cohen; Russell Johnson; Kunal Aggarwal; Sung-Youl Ko; Eun Sung Yang; Rebecca S Pelc; Kimberly A Dowd; Derek O'Hagan; Jeffrey Ulmer; Sally Mossman; Anna Sambor; Edith Lepine; John R Mascola; Theodore C Pierson; Barney S Graham; Dong Yu
Journal:  Sci Adv       Date:  2020-08-07       Impact factor: 14.136

4.  Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization.

Authors:  Shaswath S Chandrasekar; Yashdeep Phanse; Rachel E Hildebrand; Mostafa Hanafy; Chia-Wei Wu; Chungyi H Hansen; Jorge E Osorio; M Suresh; Adel M Talaat
Journal:  Vaccines (Basel)       Date:  2021-02-06

Review 5.  Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks.

Authors:  John Billington; Isabelle Deschamps; Stanley C Erck; Julie L Gerberding; Emmanuel Hanon; Sabrina Ivol; John W Shiver; Julia A Spencer; Johan Van Hoof
Journal:  Health Secur       Date:  2020-04-29

6.  SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.

Authors:  Jackson S Turner; Jane A O'Halloran; Elizaveta Kalaidina; Wooseob Kim; Aaron J Schmitz; Julian Q Zhou; Tingting Lei; Mahima Thapa; Rita E Chen; James Brett Case; Fatima Amanat; Adriana M Rauseo; Alem Haile; Xuping Xie; Michael K Klebert; Teresa Suessen; William D Middleton; Pei-Yong Shi; Florian Krammer; Sharlene A Teefey; Michael S Diamond; Rachel M Presti; Ali H Ellebedy
Journal:  Nature       Date:  2021-06-28       Impact factor: 49.962

7.  Attitudes and Acceptance of COVID-19 Vaccination Among Nurses and Midwives in Cyprus: A Cross-Sectional Survey.

Authors:  Georgia Fakonti; Maria Kyprianidou; Giannos Toumbis; Konstantinos Giannakou
Journal:  Front Public Health       Date:  2021-06-16

Review 8.  Vaccine development and therapeutic design for 2019-nCoV/SARS-CoV-2: Challenges and chances.

Authors:  Mahnaz Ghaebi; Abdolreza Osali; Hamed Valizadeh; Leila Roshangar; Majid Ahmadi
Journal:  J Cell Physiol       Date:  2020-06-18       Impact factor: 6.513

9.  Aluminum Nanoparticles Acting as a Pulmonary Vaccine Adjuvant-Delivery System (VADS) Able to Safely Elicit Robust Systemic and Mucosal Immunity.

Authors:  Ning Wang; Chunliu Wei; Zina Zhang; Ting Liu; Ting Wang
Journal:  J Inorg Organomet Polym Mater       Date:  2020-05-09       Impact factor: 3.543

10.  [A Novel Coronavirus Emerges].

Authors:  J Ena; R P Wenzel
Journal:  Rev Clin Esp       Date:  2020-02-13       Impact factor: 1.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.